Table 2.
Stone characteristics and use of ureteral stent
| All patients (n = 567) | Patients not seeking medical care within 14 days (n = 507) | Patients seeking medical care within 14 days (n = 60) | ||
|---|---|---|---|---|
| Stone location | Distal Middle Proximal Renal pelvis Bilateral |
58.4% (n = 331) 17.1% (n = 97) 13.2% (n = 75) 10.2% (n = 58) 1.1% (n = 6) |
58.4% (n = 296) 17.9% (n = 91) 13.2% (n = 67) 9.5% (n = 48) 1.0% (n = 5) |
58.3% (n = 35) 10.0% (n = 6) 13.3% (n = 8) 16.7% (n = 10) 1.7% (n = 1) |
| Stone size | ≤2 mm >2≤4 mm >4-≤6 mm >6≤10 mm >10 mm |
1.8%(n = 10) 18.0% (n = 102) 32.3% (n = 183) 40.2% (n = 228) 7.7% (n = 44) |
1.6% (n = 8) 18.1% (n = 92) 33.2% (n = 168) 39.3% (n = 199) 7.9% (n = 40) |
3.3% (n = 2) 16.7% (n = 10) 25.0% (n = 15) 48.3% (n = 29) 6.7 (n = 4) |
| Stone size at follow-up | No residual stones ≤2 mm >2≤4 mm >4-≤6 mm >6≤10 mm >10 mm No follow-up Patient no-show No longer in Scania |
59.8% (n = 339) 3.5% (n = 20) 3.2% (n = 18) 5.8% (n = 33) 2.8%(n = 16) 1.1% (n = 6) 21.7% (n = 123) 1.9% (n = 11) 0.2% (n = 1) |
59.2% (n = 300) 3.4% (n = 17) 2.4% (n = 12) 5.6% (n = 28) 3.0% (n = 15) 1.0% (n = 5) 23.5% (119) 2.0% (n = 10) 0.2% (n = 1) |
65.0% (n = 39) 5.0% (n = 3) 10.0% (n = 6) 8.4% (n = 5) 1.7% (n = 1) 1.7% (n = 1) 6.7% (n = 4) 1.7% (n = 1) – |
| Ureteral stent | Before After |
15.9% (n = 90) 34.4% (n = 195) |
15.8% (n = 80) 34.3% (n = 174) |
16.7% (n = 10) 35.0% (n = 21) |
| SFR | 90.7 (n = 515) | 90.3% (n = 458) | 88.3% (n = 53) |
SFR – stone-free rate